Mc Carthy Asset Management, Inc. Acadia Pharmaceuticals Inc Transaction History

Mc Carthy Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$13.01 - $27.22 $21,674 - $45,348	-1,666 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$16.79 - $27.09 $4,499 - $7,260	-268 Reduced 13.86%	1,666 $39,000
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $40,980 - $64,327	-2,597 Reduced 57.32%	1,934 $32,000
Q2 2021 Aug 05, 2021	BUY	$19.4 - $27.42 $45,221 - $63,916	2,331 Added 105.95%	4,531 $111,000
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $28,297 - $62,193	-1,131 Reduced 33.95%	2,200 $57,000
Q4 2020 Feb 01, 2021	BUY	$41.04 - $56.79 $136,704 - $189,167	3,331 New	3,331 $178,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.